Enzo Biochem Inc (ENZ)
1.04
0.00 (0.00%)
USD |
NYSE |
May 03, 16:00
1.045
0.00 (0.00%)
Pre-Market: 20:00
Enzo Biochem Enterprise Value: -3.432M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -3.432M |
| May 02, 2024 | -3.432M |
| May 01, 2024 | -3.432M |
| April 30, 2024 | -3.432M |
| April 29, 2024 | -2.408M |
| April 26, 2024 | -2.92M |
| April 25, 2024 | -1.896M |
| April 24, 2024 | -2.408M |
| April 23, 2024 | -0.871M |
| April 22, 2024 | -0.871M |
| April 19, 2024 | -0.871M |
| April 18, 2024 | 1.178M |
| April 17, 2024 | 2.203M |
| April 16, 2024 | 2.203M |
| April 15, 2024 | 2.715M |
| April 12, 2024 | 3.227M |
| April 11, 2024 | 3.739M |
| April 10, 2024 | 5.276M |
| April 09, 2024 | 4.764M |
| April 08, 2024 | 4.764M |
| April 05, 2024 | 7.837M |
| April 04, 2024 | 8.350M |
| April 03, 2024 | 7.837M |
| April 02, 2024 | 8.862M |
| April 01, 2024 | 7.325M |
| Date | Value |
|---|---|
| March 28, 2024 | 8.350M |
| March 27, 2024 | 8.350M |
| March 26, 2024 | 7.325M |
| March 25, 2024 | 7.325M |
| March 22, 2024 | 7.837M |
| March 21, 2024 | 5.276M |
| March 20, 2024 | 5.788M |
| March 19, 2024 | 6.301M |
| March 18, 2024 | 7.325M |
| March 15, 2024 | 5.276M |
| March 14, 2024 | 7.837M |
| March 13, 2024 | 6.301M |
| March 12, 2024 | 8.350M |
| March 11, 2024 | 10.40M |
| March 08, 2024 | 10.44M |
| March 07, 2024 | 10.44M |
| March 06, 2024 | 10.44M |
| March 05, 2024 | 10.44M |
| March 04, 2024 | 11.96M |
| March 01, 2024 | 10.44M |
| February 29, 2024 | 10.44M |
| February 28, 2024 | 10.44M |
| February 27, 2024 | 10.95M |
| February 26, 2024 | 10.95M |
| February 23, 2024 | 12.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.52M
Minimum
Sep 15 2023
163.66M
Maximum
Mar 16 2021
82.95M
Average
90.86M
Median
Oct 20 2022
Enterprise Value Benchmarks
| Delcath Systems Inc | 119.14M |
| Star Equity Holdings Inc | 12.11M |
| Exact Sciences Corp | 12.85B |
| CytoSorbents Corp | 38.69M |
| Progyny Inc | 2.690B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.061M |
| Revenue (Quarterly) | 8.553M |
| Total Expenses (Quarterly) | 9.977M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 49.39% |
| Profit Margin (Quarterly) | -35.79% |
| Earnings Yield | 64.42% |
| Normalized Earnings Yield | -6.994 |